Dapsone is administered orally as a 100 mg book or alternatively as 25 mg tablets.
To accordance with dapsone-resistant leprosy cases, multidrug assay was conflicting by WHO in 1981; dapsone is administered alternating with rifampin and clofazimine or added antileprotic drugs.
Dapsone is administered transdermally (via the skin) as a gel 5% abreast abscess medication and attainable in 3-, 30-, and 60-gram tubes. In acclimatized use, 0.5 grams should be administered to the face per apparatus active a day.